Management of Atypical Endometrial Hyperplasia with Concurrent LSIL
This 52-year-old woman requires hysterectomy as definitive treatment for her atypical endometrial hyperplasia, with concurrent colposcopy and management of her cervical LSIL according to standard protocols. The atypical endometrial hyperplasia takes priority given its high risk of concurrent endometrial cancer (up to 50%) and progression to malignancy 1.
Primary Management: Endometrial Disease
Immediate Evaluation Required
The atypical endometrial hyperplasia diagnosis from D&C demands urgent action because:
- Up to 50% of patients with atypical hyperplasia have concurrent endometrial cancer on final hysterectomy specimen 1
- The mention of a possible endometrial polyp is concerning—52% of hyperplasias found in polyps also involve the surrounding endometrium 2
- At age 52, this patient is in the peak age range for endometrial cancer risk
Definitive Treatment
Hysterectomy with bilateral salpingo-oophorectomy is the standard of care 1, 3. This is not a candidate for conservative management because:
- Conservative (fertility-sparing) treatment is only considered in younger women desiring fertility 4
- Even with conservative management, the progression risk to cancer necessitates progestin therapy and intensive surveillance 1
- Given her age and completed childbearing (presumed), surgical management eliminates cancer risk definitively
Pre-operative Workup
Before hysterectomy:
- Pelvic MRI to assess for myometrial invasion or adnexal involvement 4
- Expert gynecologic pathology review of the D&C specimen 4
- Consider Lynch syndrome screening (immunohistochemistry for MLH1, MSH2, MSH6, PMS2) given endometrial pathology 5, 6
Concurrent Cervical Management
LSIL Approach
The low-grade squamous intraepithelial lesion requires colposcopy but does not alter the primary surgical plan:
- Colposcopy is recommended for LSIL 7
- HPV testing is not useful here as 80-85% of LSIL cases are HPV-positive 8
- Colposcopy can be performed at the time of hysterectomy or pre-operatively 7
Key Consideration
If colposcopy reveals CIN 2,3 or worse, this may influence the surgical approach:
- Standard hysterectomy remains appropriate for most cases
- If invasive cervical cancer is discovered, referral to gynecologic oncology for modified radical hysterectomy may be needed 9
Surgical Planning
Refer to gynecologic oncology for surgical management 5. The procedure should include:
- Total hysterectomy with bilateral salpingo-oophorectomy
- Careful inspection of the uterus and adnexa
- Peritoneal washings if cancer is suspected
- Consider lymph node assessment if endometrial cancer is confirmed intraoperatively (based on frozen section)
Important Pitfall
Do not pursue conservative management with progestins in this age group—even though the levonorgestrel IUD shows higher regression rates than oral progestins 1, the 40-50% risk of concurrent cancer makes this unacceptable without definitive exclusion of malignancy, which cannot be reliably achieved with sampling alone.
Post-operative Management
After hysterectomy with final pathology:
- If atypical hyperplasia confirmed without cancer: routine surveillance, no additional treatment needed
- If endometrial cancer identified: stage-appropriate adjuvant therapy per gynecologic oncology
- For the cervical LSIL: if not addressed at hysterectomy, vaginal cuff cytology surveillance per standard post-hysterectomy protocols 9
Clinical Pearls
- The combination of heavy bleeding and atypical hyperplasia at age 52 strongly suggests underlying endometrioid neoplasia
- Do not be falsely reassured by the D&C—sampling error is common, and polyps may harbor more advanced disease 2
- The LSIL is a secondary concern that should not delay definitive management of the endometrial pathology
- Ensure genetic counseling is offered given the endometrial pathology and potential Lynch syndrome association 5